Lenvatinib and pembrolizumab plus FOLFOX-hepatic arterial infusion chemotherapy in locally advanced, potentially resectable hepatocellular carcinoma

doi:10.4251/wjgo.v18.i7.118522

Home
English
- English
- 简体中文
Sign In
Help Desk
Journals
Login

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Featured Articles

Journals

Submit a Manuscript

Home / Archive / Volume 18, Issue 7

This Article

Abstract
Core Tip
Full Article (XML)
Full Article (HTML)
Audio
Citation of This Article

CrossRef
Google Scholar

Similar Articles (1937)
Timeline of Article Publication (0)
Reference Citation Analysis (0)

(0)

Peer-Review Report of This Article

Answering Reviewers (PDF)
Peer-Review Report (PDF)

CrossCheck and Google Search of This Article

CrossCheck Report (PDF)

Academic Rules and Norms of This Article

Biostatistics Statement (PDF)
Conflict-of-Interest Statement (PDF)
Copyright Assignment (PDF)
Informed Consent Statement (PDF)
Institutional Review Board Statement (PDF)

Citation of this article

Chen X, Liao H, Chen J, Peng LH, Zhang JH, Xuyun XX, Chen YJ, Chen T. Lenvatinib and pembrolizumab plus FOLFOX-hepatic arterial infusion chemotherapy in locally advanced, potentially resectable hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(7): 118522 [DOI: 10.4251/wjgo.v18.i7.118522]

Corresponding Author of This Article

Tao Chen, PhD, Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, No. 107 Yanjiang West Road, Yuexiu District, Guangzhou 510120, Guangdong Province, China. ct0498@126.com

Research Domain of This Article

Oncology

Article-Type of This Article

research-article

Open-Access Policy of This Article

This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Times Cited Counts in Google of This Article

Lenvatinib and pembrolizumab plus FOLFOX-hepatic arterial infusion chemotherapy in locally advanced, potentially resectable hepatocellular carcinoma

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Share the Article

Chen X, Liao H, Chen J, Peng LH, Zhang JH, Xuyun XX, Chen YJ, Chen T. Lenvatinib and pembrolizumab plus FOLFOX-hepatic arterial infusion chemotherapy in locally advanced, potentially resectable hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(7): 118522 [DOI: 10.4251/wjgo.v18.i7.118522]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

- Full Article (XML)

Invalid Article

Reference Citation Analysis PubMed PubMed Central

Preprints.org Scopus Google Scholar